Malkhey Verma
Varanasi, UP, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Mechanistic Insights Into Aflatoxin B1-Induced Histopathology in the Gill, Liver, and Kidney Tissues and Immune Dysregulation by Altering the Expression of Cytokine Genes in Channa punctata.
Journal: Journal of applied toxicology : JAT
Published: March 10, 2026
Targeting myeloid cell leukemia-1 protein to identify potential compounds for chronic myeloid leukemia treatment: Molecular docking and molecular dynamics simulation approaches.
Journal: Biochemical and biophysical research communications
Published: September 11, 2025
Computational insights into CHST11 and CHST13: homology modeling, molecular docking, and dynamics simulation for novel therapeutic targeting in cancers.
Journal: Biochemical and biophysical research communications
Published: May 21, 2025
Potential therapeutic targets in chronic myeloid leukemia.
Journal: Medical oncology (Northwood, London, England)
Published: March 18, 2025
Organ-targeted drug delivery systems (OTDDS) of poly[(N-acryloylglycine)-co-(N-acryloyl-L-phenylalanine methyl ester)] copolymer library and effective treatment of triple-negative breast cancer.
Journal: Journal of materials chemistry. B
Published: February 25, 2025
CRISPR/Cas9: efficient and emerging scope for Brassica crop improvement.
Journal: Planta
Published: January 31, 2025
miRNA expression based modulation: A new paradigm for the treatment of chronic myeloid leukemia.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: December 07, 2024
Analysis of the Inhibitory Effect of hsa-miR-145-5p and hsa-miR-203a-5p on Imatinib-Resistant K562 Cells by GC/MS Metabolomics Method.
Journal: Journal of the American Society for Mass Spectrometry
Published: September 14, 2023
Role of miRNAs to control the progression of Chronic Myeloid Leukemia by their expression levels.
Journal: Medical oncology (Northwood, London, England)
Published: July 08, 2023
Control of Ph+ and additional chromosomal abnormalities in chronic myeloid leukemia by tyrosine kinase inhibitors.
Journal: Medical oncology (Northwood, London, England)
Published: May 08, 2023
Antileukemic Activity of hsa-miR-203a-5p by Limiting Glutathione Metabolism in Imatinib-Resistant K562 Cells.
Journal: Current issues in molecular biology
Published: November 18, 2022
Developing therapeutic approaches for chronic myeloid leukemia: a review.
Journal: Molecular and cellular biochemistry
Published: July 15, 2022
Last Updated: 09/26/2026